Non-invasive loco-regional therapy for hepatocellular carcinoma

Seminars in Surgical Oncology

Volumn 12, Issue 3, 1996, Pages 189-192

  Tanikawa, Kyuichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

arterial chemotherapy; implantable injection port; multicentric development; percutaneous ethanol injection therapy; transcatheter arterial chemoembolization

Indexed keywords

ALCOHOL;

ARTICLE; ARTIFICIAL EMBOLISM; CANCER SIZE; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0029989105     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2388(199605/06)12:3<189::aid-ssu8>3.3.co;2-g     Document Type: Article

References (15)

1. Tanikawa K: Multidisciplinary treatment of hepatocellular carcinoma. In Tobe T, Kameda H, Okudaira M, et al. (eds): ''Primary Liver Cancer in Japan." Tokyo: Springer-Verlag, 1992, 327-334.
2. Sugiura N, Tanaka K, Ohto M, et al.: Treatment of small hepatocellular carcinoma by percutaneous injection of ethanol into tumor with real-time ultrasound monitoring. Acta Hepatol Jpn 24:920, 1983.
3. Tanikawa K, Majima Y: Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma. Hepatogastroenterology 40:324-327, 1993.
4. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan-sixth report. Cancer 60:1400-1411, 1987.
5. Tanikawa K, Tanaka M: Long term prognosis of percutaneous ethanol injection therapy for hepatocellular carcinoma. In Omata M (ed): "Viral Hepatitis and Hepatocellular Carcinoma-Advance in Treatment and Future Prospects", Tokyo: Health Publishers, 1995, 161-170 (in Japanese).
6. Ikeda K, Saito S, Kawanishi M, et al.: A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18:47-53, 1993.
7. Kato Y, Nakata K, Nagataki S, et al.: Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Cancer 74:2234-2238, 1994.
8. Tanikawa K: Noninvasive treatment for hepatocellular carcinoma. In Nishioka N, Suzuki H, Mishiro S, Oda T (eds): Viral Hepatitis and Liver Disease." Tokyo: Springer-Verlag, 1994, 774-777.
9. Tanaka K, Okazaki H, Nakamura S, et al.: Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology 179:713-717, 1991.
10. Tanikawa K, Tanaka M: Treatment of advanced hepatocellular carcinoma J Intern Med 34:300-302, 1995.
11. Spigos DG, Jonasson O, Mozes M, et al.: Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol 132:777-782, 1979.
12. Oka H, Yamamoto S, Kuroki T, et al.: Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saikoto (TJ-9). Cancer 76:743-749, 1995.
13. 1 phase. Cancer Res 54:448-454, 1994.
14. Okita K, Li Q, Murakamio T, Takahashi M: Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur J Cancer Prev 2:169-176, 1993.
15. Muto Y, Moriwaki H, Ninomiya M, et al.: A novel compound of polyprenoic acids reduced recurrence rates of hepatocellular carcinoma: a double-blind controlled clinical trial. Presented in the 31st Annual Meeting of Japan Society of Hepatology at Fukuoka, Japan, July 1995